United Kingdom extends CBD food deadline after complaints

British food regulators hit the pause button on plans to winnow edible CBD products that can be sold in the United Kingdom.

United Kingdom legalizes medical cannabis prescriptions

Medical marijuana will be available by prescription in the United Kingdom by autumn after it was formally approved by the government Thursday.

After the UK’s medical cannabis market opens in the fall, it will immediately become one of the largest in Europe.

Hawthorne buys Flowr’s cannabis research facility for CA$16 million 

Hawthorne Canada completed the purchase of The Flowr Corp.’s Kelowna research and development facility for 15.9 million Canadian dollars ($12.4 million), the companies announced Wednesday.

Canadian cannabis producer Flowr cuts 40% of staff, sells assets to save cash 

Canadian cannabis producer The Flowr Corp. eliminated 40% of its workforce and sold a large parcel of land in a bid to save cash.

EU pause on CBD won’t affect thousands of products on UK shelves – for now

British health regulators say that thousands of CBD products currently on store shelves in the United Kingdom aren’t in immediate danger of removal because European Union officials are delaying plans to authorize CBD-infused foods and dietary supplements.

European Union taps the brakes on CBD foods and supplements

European Union regulators are hitting the pause button on plans to allow CBD to be sold over the counter and added to foods and dietary supplements.

As more states legalize marijuana, CBD retailers face an identity crisis

Legal and lightly taxed, CBD operators have enormous business advantages compared to their colleagues growing and selling high-THC cannabis and its extracts.

But how will they fit in the overall cannabis industry when all THC levels – think recreational marijuana – are legal?

The future of cannabis retail amid complex regulations: Q&A with Your CBD Store executives

Jay Benge and Ryan Sinclair of Your CBD Store discuss how a large, multistate cannabis retailer captures the wellness-minded consumer amid complex regulations,

Can potential growth aid this cannabis stock? + strategic planning alternative

The Kanabo Group is banking on potential growth to correct its stock trend, and how to best use scenario planning in lieu of strategic planning.

Court tosses Canopy cannabis patent infringement lawsuit against GW Pharma

A Texas court has dismissed a lawsuit brought by Canadian cannabis producer Canopy Growth against GW Pharmaceuticals, although Canopy has the right to appeal the ruling.